However, even if this compound can efficiently block the CCL1/CCR8 axis in vitro, it failed to demonstrate an efficacy in vivo in a primate model [319], thus stopping the evaluation of CCR8 inhibition for the treatment of asthma. Here, CCR8 is linked to asthma.